Beating 'mini-heart' derived from patient's blood cells offers personalized disease model
Researchers at McGill University have developed a 3D 'heart-on-a-chip' using blood cells from a patient with dilated cardiomyopathy. This model allows scientists to study heart disease mechanisms and test personalized treatments outside the human body.
Why it matters
This technology advances personalized medicine by providing a more accurate human-based model for drug testing compared to traditional animal or cell-culture methods.
edited by Lisa Lock , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in